Citadel Advisors - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 14 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,000
-88.0%
12,100
-71.9%
0.00%
Q2 2022$25,000
-78.3%
43,100
-75.2%
0.00%
Q1 2022$115,000
+161.4%
173,711
+321.6%
0.00%
Q4 2021$44,000
-25.4%
41,200
-10.5%
0.00%
Q3 2021$59,000
-62.2%
46,041
-41.4%
0.00%
Q2 2021$156,000
-91.2%
78,524
-88.0%
0.00%
Q1 2021$1,765,000
+187.0%
653,846
+219.5%
0.00%
Q4 2020$615,000
+131.2%
204,628
+281.1%
0.00%
Q3 2020$266,000
+97.0%
53,687
+57.9%
0.00%
Q2 2020$135,00034,0030.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
QS Investors, LLC 82,000$247,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders